NASDAQ · Healthcare · Medical - Pharmaceuticals
Rein Therapeutics Inc.
RNTX
Rein Therapeutics Inc. CEO James Brian Windsor · Market cap $27.2M.
$0.97
+0.04 · +3.83%
52w hi $2.1852w lo $0.86
Off 52w high 51.7%
67
NOTABLE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
0 strong · 2 notable
Analyst consensus
Hold
Avg PT $6.00
Section 01
Recent Form 4 filings
5 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Apr 30 | James Brian Windsor | President and Chief Executive Officer | Buy | 25,000 | $1.00 | +$25K | 67 |
| Nov 14 | Voss Capital, LP | Buy | 104,183 | $1.22 | +$128K | 60 | |
| Oct 28 | Voss Capital, LP | Buy | 178,392 | $1.39 | +$248K | 59 | |
| Oct 27 | Voss Capital, LP | Buy | 92,642 | $1.37 | +$127K | 52 | |
| Oct 24 | Voss Capital, LP | Buy | 30,176 | $1.39 | +$42K | 35 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun